Skip to content
Search

Latest Stories

PSNC calls for price concession fix as system is no longer working for pharmacy contractors

The Pharmaceutical Services Negotiating Committee (PSNC)’s members are seeking immediate rescue packages for the sector to help with energy bills and to ease capacity constraints.

In a meeting held on 14th and 15th September, the committee members expressed their anger and frustration on the reluctance of NHS England and government to fund pharmacy sustainably.


The meeting was held to consider practical steps to ease the pressures on the community pharmacy sector, and to oversee the progress of negotiations on the Community Pharmacy Contractual Framework (CPCF) and other work.

Committee members, as pharmacy contractors, shared their experiences of the current pressures on all contractors, including the inability to deliver some services and to maintain core service levels; the capacity and workforce crises facing the sector; the critical need for funding support this winter; and the urgent need for Government to adapt the Price Concessions system to meet the needs of contractors.

The Price Concessions system is no longer working for contractors in the current volatile medicine supply environment and PSNC is clear this is not acceptable,” said the committee.

“We have sent a strong and clear message back to Government that pharmacies cannot subsidise the NHS medicines bill, escalating this within the Department of Health and Social Care (DHSC) and insisting that they find urgent solutions.”

Over the reluctance of NHS England and Government to fund pharmacy sustainably, PSNC said, it ‘will lead the sector in holding them to account for this, including through the work to develop a new vision and strategy for the community pharmacy sector.’

A deal on Year 4 of the five-year CPCF was agreed in principle over the summer but is awaiting final cross-government approval following ministerial resignations in the summer.

The committee reconsidered this in light of the rapidly worsening economic outlook for community pharmacies.

The Committee also considered funding delivery, looked at key service-related consultations, and made early decisions on PSNC’s Transforming Pharmacy Representation (TAPR) work.

As part of the TAPR work, they considered key questions about PSNC’s governance – ahead of a full governance review – and contractor levies, and these will be discussed at the upcoming LPC Conference before announcements are made to contractors.

At the LPC Conference in Manchester this week (September 22), PSNC members and LPCs came together to explore further practical solutions to the pressures facing contractors and to look at how local and national representatives can best collaborate on those.

Prior to the meeting, PSNC chief executive Janet Morrison said: “PSNC’s committee members, all of whom are community pharmacy contractors or representatives of contractors, have this month reflected the anger and frustration that is being felt across the sector.

Pharmacies stepped up during the pandemic to deliver all that the government and NHS needed, yet you are now struggling to keep afloat while those same two organisations allow Drug Tariff and concession price issues, spiralling costs, and other pressures to decimate your businesses. This is not acceptable to us, it is not acceptable to NHS patients, and it won’t be acceptable to the public: PSNC is clear that policy-makers must be held to account for it.

“We are continuing to take a very hard line on all of these issues, alongside ramping up our influencing and data-gathering work as we seek short-term solutions for all contractors. During the pandemic we and the wider the sector fought very hard for contractors’ Covid costs to be covered and that is what we will do again now, with energy prices, with Price Concessions, and with overall funding levels. Thank you once again to all those contractors who have contacted us about these issues and for all the evidence you provide on an ongoing basis – we will be needing more of this soon.”

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Pharmacy First: Government confirms £215 million boost to realise its full potential

From April 2025, the consultation fee for Pharmacy First Minor Illness and Clinical Pathways will rise from £15 to £17.

‘Pharmacy First hasn't realised its full potential,’ says Stephen Kinnock

Health Minister Stephen Kinnock has acknowledged that Pharmacy First has huge potential, noting that the service “hasn't realised its full potential.”

As part of efforts to enhance the service, Kinnock yesterday (30) announced £215 million in additional funding for Pharmacy First and other Primary Care Access Recovery Plan services.

Keep ReadingShow less
New CPCF funding: “This is the best deal community pharmacy has had in a decade”

This new funding settlement marks a significant step forward in addressing the long term underinvestment in community pharmacy, says RPS England chair Tase Oputu

Pharmacy bodies hail new funding settlement as ‘best deal for community pharmacy in a decade’

Pharmacy bodies have welcomed the new funding settlement for community pharmacies, highlighting its potential to enhance patient access to care and medicines while addressing a decade of underinvestment in the sector.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a record £3.073 billion funding package for 2025/26, along with an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less